Relative risk reduction (RRR) is a way of expressing how much a treatment lowers the chance of a bad outcome compared to not having the treatment. It’s shown as a percentage, and it answers the question: “Of the risk that existed before, how much did the treatment remove?” A treatment with a 40% relative risk reduction, for example, cut the original risk by four-tenths. That sounds straightforward, but the number can be deeply misleading if you don’t know the starting risk, which is why understanding RRR matters every time you read a health headline.
How Relative Risk Reduction Is Calculated
The math behind RRR is simple once you know two numbers: the event rate in the control group (people who didn’t get the treatment) and the event rate in the treatment group (people who did). You subtract the treatment group’s rate from the control group’s rate, then divide by the control group’s rate.
Say a study finds that 20 out of 100 people in the control group develop a complication, compared to 12 out of 100 in the treatment group. The control event rate is 20%, the treatment event rate is 12%, and the difference is 8 percentage points. Divide that 8 by the original 20%, and you get 0.40, or a 40% relative risk reduction.
That 40% figure tells you the treatment cut the risk by 40% relative to what it was. It does not mean 40 fewer people out of every 100 avoided the outcome. That distinction trips up a lot of readers, and it’s the single most important thing to grasp about RRR.
Why RRR Can Be Misleading on Its Own
Relative risk reduction stays roughly the same regardless of how high or low someone’s baseline risk is. This is a well-documented property: if a drug cuts risk by 40% in a high-risk group, it tends to cut risk by about 40% in a low-risk group too. The problem is that 40% of a large number is very different from 40% of a tiny one.
Consider two patients. One has a 50% chance of a heart event over the next ten years; the other has a 2% chance. A drug with a 40% RRR drops the first patient’s risk from 50% to 30%, preventing 20 events per 100 people. It drops the second patient’s risk from 2% to 1.2%, preventing fewer than 1 event per 100 people. Same relative risk reduction. Vastly different real-world impact.
This is sometimes called the “mirage effect.” A headline reporting a 40% risk reduction sounds dramatic, but without knowing the starting risk, you can’t tell whether the benefit is life-changing or barely noticeable. Real trial data illustrates this clearly: in statin research, patients with heavy coronary plaque (high baseline risk) saw a 42% to 44% relative risk reduction, which translated to a 6 to 8.5 percentage-point absolute drop in events. Patients with little or no plaque saw essentially no benefit at all, despite the same drug and the same relative framework.
Absolute Risk Reduction: The Missing Piece
Absolute risk reduction (ARR) is the straightforward difference between the two event rates. In the earlier example where the control group had a 20% event rate and the treatment group had 12%, the ARR is simply 8 percentage points. It tells you the actual size of the benefit in terms you can picture: 8 fewer people out of every 100 experienced the bad outcome.
ARR changes with baseline risk in a way RRR does not. High-risk patients get a larger absolute benefit from the same treatment. Low-risk patients get a smaller one. This is why ARR is considered the more useful number for making personal health decisions. Risk-benefit and cost-benefit analyses rely on absolute risks rather than relative ones for exactly this reason.
From ARR, you can also calculate the number needed to treat (NNT), which tells you how many people need to receive the treatment for one person to benefit. The formula is simply 1 divided by the ARR. If the ARR is 25% (0.25), the NNT is 4: you’d need to treat 4 people for 1 to avoid the bad outcome. If the ARR is smaller, say 0.089 (about 8.9%), the NNT rises to roughly 11. The higher the NNT, the more people you need to treat before one person benefits, which helps put the practical value of a treatment in perspective.
How Framing Affects Decisions
The way risk numbers are presented genuinely changes how people react. When patients hear “this drug reduces your risk by 50%,” they’re far more inclined to accept treatment than when they hear “this drug lowers your risk from 4% to 2%.” Both statements describe the same data. The first uses relative framing; the second uses absolute framing. Neither is wrong, but they create very different impressions.
This has been a point of tension in medical publishing. Critics have called out major trials for reporting only relative risk reduction, arguing that absolute risk reduction and number needed to treat should always appear alongside it. The CONSORT guidelines for clinical trial reporting stop short of requiring both, but they do advocate that authors provide enough raw data for readers to calculate whichever measure they find most informative. In practice, many journals now present both, though headlines and press releases still tend to favor the more impressive-sounding relative number.
How to Read RRR in a Study or News Article
When you encounter a relative risk reduction figure, three questions will help you evaluate what it actually means for you or someone you care about:
- What was the baseline risk? A 50% RRR sounds impressive, but if the original risk was 1 in 1,000, the treatment is preventing 0.5 events per 1,000 people. Look for the control group’s event rate.
- What is the absolute risk reduction? Subtract the treatment group’s event rate from the control group’s. This gives you the real-world size of the benefit.
- What is the number needed to treat? Divide 1 by the ARR. If the NNT is 4, the treatment has a strong practical impact. If it’s 200, the benefit is real but spread very thin across a large population.
You can’t fully understand risk without seeing both the absolute and relative numbers side by side. Relative risk reduction tells you how effective a treatment is in proportional terms. Absolute risk reduction tells you how much that proportion matters given your starting point. Together, they give you the complete picture.